Sun Pharmaceutical Industries to acquire around 37.76% stake in EzeRx

06 Oct 2023 Evaluate

Sun Pharmaceutical Industries has entered into an agreement to acquire around 37.76% equity shareholding of Ezerx Health Tech (EzeRx). Cost of acquisition will be Rs 28.69 crore. EzeRx is engaged in the production, marketing and distribution of non-invasive diagnostic and ancillary medical devices in and outside India.

Besides, the company has executed an additional agreement to acquire further around 4.04% equity shares in Agatsa Software (Agatsa) from existing shareholders resulting in total proposed acquisition of stake to go up to around 30.13% of Agatsa. Earlier, the company had acquired around 26.09% shares in Agatsa. Agatsa is engaged in research, development and commercialization of medical devices in the health diagnostics segment by leveraging technology and R&D capabilities.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1653.90 -19.65 (-1.17%)
20-Jan-2026 11:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1653.90
Dr. Reddys Lab 1170.15
Cipla 1390.00
Zydus Lifesciences 879.85
Lupin 2165.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×